Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA
Fig 2
Urinary 24-h excretion of 52Cr-EDTA/creatinine for different subgroups of CD patients according to the Montreal classification of disease localization.
No significant differences were observed between any groups (P > 0.05).